文献检索，用中文搜 PubMed

1

Creating real benefit for patients at risk of nausea and vomiting: palonosetron-from bench to bedside.为面临恶心和呕吐风险的患者创造切实益处：帕洛诺司琼——从实验室到临床应用

Clin Adv Hematol Oncol. 2007 Dec;5(12 Suppl 19):1-20.

2

International Symposium on Xenotransplantation. A satellite symposium held in conjunction with the fourth congress of the European Society for Transplantation. November 1, 1989, Barcelona, Spain.

Transplant Proc. 1990 Jun;22(3):1055-361.

3

Interferon therapy--molecular mechanisms and clinical applications. Proceedings of a satellite symposium held at the 4th European Conference on Clinical Oncology and Cancer Nursing. Madrid, Spain, 1st-4th November 1987.

Br J Clin Pract Suppl. 1988 Mar;62:1-26.

4

A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72-hour period.一项随机、双盲研究，旨在评估三种不同剂量的帕洛诺司琼与安慰剂在预防72小时内术后恶心和呕吐方面的疗效和安全性。

Anesth Analg. 2008 Aug;107(2):439-44. doi: 10.1213/ane.0b013e31817abcd3.

5

A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo for preventing postoperative nausea and vomiting.一项随机、双盲研究，旨在评估三种不同剂量的帕洛诺司琼与安慰剂预防术后恶心和呕吐的疗效及安全性。

Anesth Analg. 2008 Aug;107(2):445-51. doi: 10.1213/ane.0b013e31817b5ebb.

6

[Croatian guideliness for prevention of chemotherapy induced nausea and vomiting].[克罗地亚化疗所致恶心和呕吐预防指南]

Lijec Vjesn. 2009 Mar-Apr;131(3-4):49-53.

7

Palonosetron--a single-dose antiemetic adjunct for hepatic artery radioembolization: a feasibility study.

Cardiovasc Intervent Radiol. 2009 Jan;32(1):47-51. doi: 10.1007/s00270-008-9428-z. Epub 2008 Sep 9.

8

Randomized, placebo-controlled, pilot study evaluating aprepitant single dose plus palonosetron and dexamethasone for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.一项随机、安慰剂对照的试点研究，评估阿瑞匹坦单剂量联合帕洛诺司琼和地塞米松预防化疗引起的急性和延迟性恶心和呕吐。

Cancer. 2008 May 1;112(9):2080-7. doi: 10.1002/cncr.23364.

9

Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: comparison between elderly and non-elderly patient response.帕洛诺司琼联合地塞米松可有效预防既往接受过止吐治疗但无反应的预处理患者在接受高度或中度致吐性化疗后出现的急性和迟发性化疗引起的恶心和呕吐：老年与非老年患者反应的比较。

Crit Rev Oncol Hematol. 2009 Apr;70(1):83-91. doi: 10.1016/j.critrevonc.2008.07.002. Epub 2008 Aug 23.

10

Is hypertension a metabolic disease? Do we have to reevaluate our way of thinking? Proceedings of a satellite symposium to the 14th Congress of the European Society of Cardiology. Barcelona, Spain, September 2, 1992.高血压是一种代谢性疾病吗？我们是否必须重新评估我们的思维方式？欧洲心脏病学会第14届大会卫星研讨会会议记录。西班牙巴塞罗那，1992年9月2日。

Am Heart J. 1993 May;125(5 Pt 2):1485-546.

Suppr 超能文献

文献检索

文件翻译

深度研究

Suppr 超能文献

为面临恶心和呕吐风险的患者创造切实益处：帕洛诺司琼——从实验室到临床应用

Creating real benefit for patients at risk of nausea and vomiting: palonosetron-from bench to bedside.

作者信息

机构信息

出版信息